Breaking News

Agilent Launches Advanced Therapeutics CDMO Solution for US and Canada

Agilent Advanced Therapeutics brings together BIOVECTRA, in Canada, and Nucleic Acid Solutions in Colorado.

Author Image

By: Patrick Lavery

Content Marketing Editor

Agilent Technologies is launching Agilent Advanced Therapeutics, a unified CDMO solution integrating expanding capabilities across Canada and the United States. To begin, Agilent Advanced Therapeutics’ CDMO portfolio encompasses oligonucleotides, microbial fermentation, both complex and synthetic chemistry, and bioreagents. Also included: highly potent active pharmaceutical ingredients, and cell line development. Bringing US and Canada Together Agilent says the new arrangement ties toge...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters